Jiangsu Sihuan Bioengineering000518 
$0.281.52%24h
1.52%24h
Global rank15068
Market cap$291.90M
Change 7d4.15%
YTD Performance-39.27%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield0.0%
Main Sector
Healthcare
Jiangsu Sihuan Bioengineering (000518) Stock Overview
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusen, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass; Xinde Lusheng; Xin Lisheng; and Ring BO. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.
000518 Stock Information
Symbol
000518Address
No. 6 ZhongfangJiangyin, 214426China
Founded
-Trading hours
-Website
https://www.000518shsw.com/shswCountry
🇨🇳 ChinaPhone Number
Jiangsu Sihuan Bioengineering (000518) Price Chart
-
Value:-
Jiangsu Sihuan Bioengineering Overview: Key Details and Summary
Stock data | 2024 | Change |
|---|---|---|
| Price | $0.2835178785527893 | N/A |
| Market Cap | $291.90M | N/A |
| Shares Outstanding | 1.03B | N/A |
| Employees | 250.00 | N/A |
Valuation | 2024 | Change |
|---|---|---|
| P/FCF | 2424.26 | N/A |
Dividends | 2024 | Change |
|---|---|---|
| Dividend Yield | 0.04% | N/A |
| Dividend per share | 0.0001 | N/A |
Growth | 2024 | Change |
|---|---|---|
| CAPEX | 905.72K | N/A |
Earnings | 2024 | Change |
|---|---|---|
| Free Cash Flow | $120.41K | N/A |
